Cargando…
Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
SIMPLE SUMMARY: Androgen deprivation therapy (ADT) is the gold standard treatment for advanced prostate cancer and the subsequent risk of dementia remains controversial. Previous studies were limited by small sample sizes, short follow-up times, and racial differences. In this population-based cohor...
Autores principales: | Liu, Jui-Ming, Shen, Chin-Yao, Lau, Wallis C. Y., Shao, Shih-Chieh, Man, Kenneth K. C., Hsu, Ren-Jun, Wu, Chun-Te, Lai, Edward Chia-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345520/ https://www.ncbi.nlm.nih.gov/pubmed/34359762 http://dx.doi.org/10.3390/cancers13153861 |
Ejemplares similares
-
Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders
por: Liu, Jui-Ming, et al.
Publicado: (2020) -
Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer
por: Jayadevappa, Ravishankar, et al.
Publicado: (2019) -
Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019) -
A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
por: Lee, C Ellen, et al.
Publicado: (2012) -
Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2020)